Stevanato Group SpA

Yahoo Finance • 9 days ago

Stevanato Group’s (STVN) Core Business Improved Despite a 22% Pull Back in Q4

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) an... Full story

Yahoo Finance • 24 days ago

Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN)

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise ch... Full story

Yahoo Finance • 27 days ago

Mid-Cap healthcare stocks ranked by quant ratings after earnings season

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of co... Full story

Yahoo Finance • last month

Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales

Earnings Call Insights: Stevanato Group (STVN) Q4 2025 MANAGEMENT VIEW * Franco Stevanato, CEO & Executive Chairman, reported that "for the fiscal 2025, total company revenue increased by 9% at constant-currency rates and 7% on a repor... Full story

Yahoo Finance • last month

Pre-Market Earnings Report for March 4, 2026 : DY, NXE, BBWI, ANF, WIX, EYE, EYPT, GENI, DAKT, STVN, OCGN, REAX

The following companies are expected to report earnings prior to market open on 03/04/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Dycom Industries, Inc. (DY)is reporting for the quarter ending Janua... Full story

Yahoo Finance • 2 months ago

Here’s What Hurt Stevanato Group SpA (STVN) in Q4

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying con... Full story

Yahoo Finance • 5 months ago

Stevanato Group reiterates 2025 outlook, projects high-value solutions to reach up to 44% of revenue as biologics demand accelerates

Earnings Call Insights: Stevanato Group S.p.A. (STVN) Q3 2025 MANAGEMENT VIEW * Franco Stevanato, CEO & Executive Chairman, reported "another solid quarter of financial results, driven by revenue growth, a record mix of high-value solu... Full story

Yahoo Finance • 6 months ago

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

Stevanato Group team members at the Bad Oeynhausen site in northern Germany are pictured during the inauguration of the new cleanroom. At the center are Franco Stevanato, CEO; Marco Dal Lago, CFO; and Michele Monico, President of DDS and I... Full story

Yahoo Finance • 7 months ago

Here’s Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN)

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global markets saw an incredible but volatile second quarter, shift... Full story

Yahoo Finance • 9 months ago

Stevanato secures €200M in financing

* Stevanato Group (NYSE:STVN [https://seekingalpha.com/symbol/STVN]) has secured [https://seekingalpha.com/pr/20174636-stevanato-group-secures-200-million-in-financing-from-bnl-bnp-paribas-cassa-depositi-e]€200 million in financing to su... Full story

Yahoo Finance • last year

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

PIOMBINO DESE, Italy, March 11, 2025--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences indu... Full story

Yahoo Finance • 2 years ago

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU"

Stevanato Group, Gerresheimer & SCHOTT Pharma join forces in the 'Alliance for RTU' (Photo: Business Wire) Market advances adoption of ready-to-use containers Improved operational efficiency in pharmaceutical manufacturing processes Incre... Full story